Rating History for Monopar Therapeutics (MNPR) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/9/2026 | Maxwell Skor | New Coverage | Overweight (N/A) |
115.00 (N/A) |
65.01 (111.12) |
70.93% | Details |
